Share on LinkedInShare on LinkedIn

ARTICLE · 11 DECEMBER 2014

Amendments Regarding Compulsory Licenses In Turkey

Article 31(f) of the TRIPS Agreement states that compulsory licenses shall be authorized ‘predominantly for the supply of the domestic market’ of the Member State authorizing the use of such license.

TurkeyInternational Law

Article 31(f) of the TRIPS Agreement1 states that compulsory licenses shall be authorized 'predominantly for the supply of the domestic market' of the Member State authorizing the use of such license. In other words, the importing country cannot grant compulsory licenses with a view to supplying a third country market. In the meantime, developing countries have long argued that the above-stated article is hampering access to medicines as only very few developing countries have a significant manufacturing capacity2. This was first mentioned in Paragraph 6 of the Doha Declaration3 as follows:

"We recognize that WTO members with insufficient or no manufacturing capacities in the pharmaceutical sector could face difficulties in making effective use of compulsory licensing under the TRIPS Agreement."

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from